Published in Am J Physiol Renal Physiol on May 12, 2010
Epigenetic modifications as therapeutic targets. Nat Biotechnol (2010) 3.16
A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol (2011) 2.51
DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J (2012) 2.21
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol (2013) 1.52
miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. Diabetes (2011) 1.47
Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes (2011) 1.47
Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res (2011) 1.43
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol Med (2011) 1.34
Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res (2011) 1.33
Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia (2014) 1.22
Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest (2011) 1.22
Library construction for next-generation sequencing: overviews and challenges. Biotechniques (2014) 1.20
Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol (2011) 1.17
Histone deacetylases as targets for treatment of multiple diseases. Clin Sci (Lond) (2013) 1.16
Stress and the epigenetic landscape: a link to the pathobiology of human diseases? Nat Rev Genet (2010) 1.13
Systems genetics of susceptibility to obesity-induced diabetes in mice. Physiol Genomics (2011) 1.10
Epigenetics in diabetic kidney disease. J Am Soc Nephrol (2011) 1.09
Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res (2010) 1.07
Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol (2011) 1.03
Epigenetic modifications in the pathogenesis of diabetic nephropathy. Semin Nephrol (2013) 1.02
Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes. J Biol Chem (2012) 1.02
Application of microdroplet PCR for large-scale targeted bisulfite sequencing. Genome Res (2011) 1.01
Understanding the epigenetic syntax for the genetic alphabet in the kidney. J Am Soc Nephrol (2013) 0.98
Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy (2011) 0.98
Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res (2015) 0.98
From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? Clin Epigenetics (2015) 0.98
Epigenetics and autoimmune diseases. Autoimmune Dis (2012) 0.97
Epigenetic modifications and diabetic retinopathy. Biomed Res Int (2013) 0.97
Vascular memory: can we broaden the concept of the metabolic memory? Cardiovasc Diabetol (2012) 0.97
Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int (2013) 0.96
Next steps in cardiovascular disease genomic research--sequencing, epigenetics, and transcriptomics. Clin Chem (2011) 0.95
Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: a proof of principle on type 2 diabetes. Aging (Albany NY) (2013) 0.94
Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC Med Genomics (2011) 0.92
Review: Epigenetic mechanisms in ocular disease. Mol Vis (2013) 0.91
The genetics of diabetic nephropathy. Genes (Basel) (2013) 0.90
Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol Endocrinol (2014) 0.90
Microplate-based platform for combined chromatin and DNA methylation immunoprecipitation assays. BMC Mol Biol (2011) 0.89
Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes (2012) 0.89
Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes. Clin Epigenetics (2015) 0.88
Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes. Diabetes (2011) 0.88
Diet-Induced Podocyte Dysfunction in Drosophila and Mammals. Cell Rep (2015) 0.85
Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing. Invest Ophthalmol Vis Sci (2013) 0.85
Type 2 diabetes mellitus in relation to global LINE-1 DNA methylation in peripheral blood: a cohort study. Epigenetics (2014) 0.85
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort. Proc Natl Acad Sci U S A (2016) 0.84
The heart-placenta axis in the first month of pregnancy: induction and prevention of cardiovascular birth defects. J Pregnancy (2013) 0.84
Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses. J Biol Chem (2011) 0.83
Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathway. Am J Pathol (2011) 0.83
Targeting metabolic disorders by natural products. J Diabetes Metab Disord (2015) 0.82
Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord (2014) 0.80
Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy. Clin Epigenetics (2014) 0.80
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Genetics of cardiovascular and renal complications in diabetes. J Diabetes Investig (2015) 0.80
Epigenetics: an expanding new piece of the stroke puzzle. Transl Stroke Res (2011) 0.79
The Role of Epigenetics in Arterial Calcification. Biomed Res Int (2015) 0.79
Relationship between blood levels of methyl donor and folate and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study. J Clin Biochem Nutr (2014) 0.78
Drugs targeting epigenetic histone acetylation in vascular smooth muscle cells for restenosis and atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 0.77
Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics. Curr Opin Pediatr (2010) 0.77
You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics. Curr Opin Clin Nutr Metab Care (2015) 0.77
Epigenetic modifications and potential new treatment targets in diabetic retinopathy. J Ophthalmol (2014) 0.77
[Update on diabetic macroangiopathy]. Pathologe (2012) 0.76
Epigenetic Mechanisms of the Aging Human Retina. J Exp Neurosci (2016) 0.76
Histone mimics: digging down under. Front Biol (Beijing) (2013) 0.76
VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis. ScientificWorldJournal (2014) 0.76
Histone lysine methylation in diabetic nephropathy. J Diabetes Res (2014) 0.76
Emerging roles of the myocardin family of proteins in lipid and glucose metabolism. J Physiol (2016) 0.76
miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal-jejunal bypass. Int J Obes (Lond) (2016) 0.76
Epigenetic modifications and diabetic nephropathy. Kidney Res Clin Pract (2012) 0.76
Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia. J Immunol (2014) 0.76
Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia. PLoS One (2016) 0.75
Metformin improves metabolic memory in high fat diet (HFD)-induced renal dysfunction. J Biol Chem (2016) 0.75
The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy. Sci Rep (2016) 0.75
Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies? OMICS (2015) 0.75
Hypoglycemic effect of Brassica juncea (seeds) on streptozotocin induced diabetic male albino rat. Asian Pac J Trop Biomed (2011) 0.75
Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy. J Diabetes Res (2016) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Translating the histone code. Science (2001) 56.77
Chromatin modifications and their function. Cell (2007) 55.98
The language of covalent histone modifications. Nature (2000) 44.92
Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature (1997) 44.55
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell (2004) 21.30
Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol (2009) 19.99
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02
The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96
The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol (2005) 12.70
miRNAs, cancer, and stem cell division. Cell (2005) 12.15
Histone demethylation by a family of JmjC domain-containing proteins. Nature (2005) 10.36
Histone acetyltransferases. Annu Rev Biochem (2001) 10.00
Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell (2007) 9.73
Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev (2001) 9.54
Epigenetic inheritance at the agouti locus in the mouse. Nat Genet (1999) 9.14
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature (2005) 8.53
Perceptions of epigenetics. Nature (2007) 8.43
Role of oxidative stress in development of complications in diabetes. Diabetes (1991) 8.27
Epigenetics in cancer. Carcinogenesis (2009) 7.49
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med (1988) 7.22
Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell (2006) 7.08
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA (2002) 6.61
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med (2003) 5.87
A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol (2008) 5.55
Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol (2002) 5.53
New nomenclature for chromatin-modifying enzymes. Cell (2007) 5.34
Dynamic regulation of histone lysine methylation by demethylases. Mol Cell (2007) 5.14
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A (2007) 4.92
CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A (1997) 4.71
The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol (2001) 4.55
An operational definition of epigenetics. Genes Dev (2009) 4.26
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol (2009) 4.05
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes (2008) 4.05
Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab (2009) 3.98
Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet (2007) 3.65
Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell (2004) 3.60
Histone acetyltransferase complexes stabilize swi/snf binding to promoter nucleosomes. Cell (2001) 3.54
Progression of incipient diabetic retinopathy during good glycemic control. Diabetes (1987) 3.30
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol (2008) 3.24
Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev (2003) 3.16
Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev (2009) 3.02
Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest (2008) 3.02
Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes (2009) 2.96
Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet (2004) 2.78
Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab (2009) 2.76
MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J (2008) 2.75
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol (2008) 2.74
Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) (2008) 2.70
Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol (2008) 2.69
Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis". Proc Natl Acad Sci U S A (2006) 2.68
Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes (2006) 2.65
H2A.Z alters the nucleosome surface to promote HP1alpha-mediated chromatin fiber folding. Mol Cell (2004) 2.63
Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner. J Biol Chem (2006) 2.59
Role of protein methylation in regulation of transcription. Endocr Rev (2004) 2.57
Histone lysine demethylases and their impact on epigenetics. Cell (2006) 2.54
Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol (2008) 2.51
The role of inflammatory cytokines in diabetes and its complications. J Periodontol (2008) 2.39
Moving AHEAD with an international human epigenome project. Nature (2008) 2.38
Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev (2009) 2.36
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature (2009) 2.35
Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes (2009) 2.34
Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A (2008) 2.33
Chromatin poises miRNA- and protein-coding genes for expression. Genome Res (2009) 2.28
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov (2009) 2.24
Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab (2008) 2.21
Polycomb proteins remain bound to chromatin and DNA during DNA replication in vitro. Cell (2009) 2.20
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A (1990) 2.18
Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem (2008) 2.17
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem (1999) 2.15
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes (1995) 2.12
In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem (2004) 2.07
Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb (1994) 2.05
DNA methylation as a biomarker for cardiovascular disease risk. PLoS One (2010) 2.04
Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor. Mol Cell Biol (2004) 2.00
Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun (2004) 1.98
Insulin gene expression is regulated by DNA methylation. PLoS One (2009) 1.97
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97
SIRT1 and insulin resistance. Nat Rev Endocrinol (2009) 1.96
Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res (2006) 1.89
Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61. Diabetes Care (2002) 1.85
Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes (2003) 1.84
MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol (2009) 1.77
Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem (2003) 1.71
Aldosterone-induced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+ channel alpha. J Clin Invest (2007) 1.69
From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes (2008) 1.65
Epigenetic inheritance of cell differentiation status. Cell Cycle (2008) 1.60
Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem (2007) 1.54
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A (2007) 4.92
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol (2009) 4.05
Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A (2008) 2.33
A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney Int (2011) 2.30
Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem (2008) 2.17
High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes (2003) 2.14
In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem (2004) 2.07
Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes (2014) 1.81
MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol (2009) 1.77
Retracted Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res (2008) 1.74
Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol (2006) 1.71
Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol (2012) 1.70
Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation. Am J Physiol Heart Circ Physiol (2009) 1.63
Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. Am J Physiol Cell Physiol (2004) 1.62
Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J (2007) 1.62
Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice. Kidney Int (2003) 1.60
Mapping global histone methylation patterns in the coding regions of human genes. Mol Cell Biol (2005) 1.55
Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem (2007) 1.54
Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem (2006) 1.52
12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem (2003) 1.50
Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes (2006) 1.49
Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology (2006) 1.47
Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes (2008) 1.46
Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol (2010) 1.44
Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res (2011) 1.43
Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J Biol Chem (2010) 1.42
Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem (2003) 1.35
Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes (2010) 1.32
PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc Natl Acad Sci U S A (2011) 1.30
Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res (2013) 1.30
Fast population coding. Neural Comput (2007) 1.26
Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol (2012) 1.26
Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia (2014) 1.22
Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol (2011) 1.17
Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation (2005) 1.17
Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Am J Physiol Renal Physiol (2008) 1.16
Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes (2013) 1.15
Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. J Lipid Res (2004) 1.15
Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J Biol Chem (2008) 1.14
Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol (2006) 1.14
Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis. Circ Res (2005) 1.12
Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem (2012) 1.09
Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J Biol Chem (2004) 1.09
Epigenetics in diabetic kidney disease. J Am Soc Nephrol (2011) 1.09
MicroRNAs: potential mediators and biomarkers of diabetic complications. Free Radic Biol Med (2013) 1.08
Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2007) 1.07
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol (2002) 1.07
Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol (2004) 1.06
Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes (2004) 1.05
Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes (2007) 1.05
Interaction of monocytes with vascular smooth muscle cells regulates monocyte survival and differentiation through distinct pathways. Arterioscler Thromb Vasc Biol (2004) 1.03
Epigenetic modifications in the pathogenesis of diabetic nephropathy. Semin Nephrol (2013) 1.02
Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes. J Biol Chem (2012) 1.02
Enhancers: multi-dimensional signal integrators. Transcription (2012) 1.02
Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb Vasc Biol (2012) 1.02
Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2008) 0.98
Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B). J Mol Cell Cardiol (2004) 0.98
TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal (2013) 0.97
MicroRNAs and the glomerulus. Exp Cell Res (2012) 0.97
FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy. J Biol Chem (2013) 0.97
12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat. Prostaglandins Leukot Essent Fatty Acids (2005) 0.96
Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b. J Biol Chem (2006) 0.93
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int (2005) 0.93
Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J Am Soc Nephrol (2003) 0.92
Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes (2007) 0.92
Histone methylation patterns are cell-type specific in human monocytes and lymphocytes and well maintained at core genes. J Immunol (2008) 0.90
MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy. Semin Nephrol (2012) 0.90
Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice. Hypertension (2003) 0.89
microRNA cascade in diabetic kidney disease: Big impact initiated by a small RNA. Cell Cycle (2009) 0.88
Using epigenetic mechanisms to understand the impact of common disease causing alleles. Curr Opin Immunol (2012) 0.87
P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. Nephrol Dial Transplant (2005) 0.86
Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC. BMC Complement Altern Med (2010) 0.85
Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. J Am Soc Nephrol (2008) 0.85
Heat shock protein 27 overexpression mitigates cytokine-induced islet apoptosis and streptozotocin-induced diabetes. Endocrinology (2009) 0.85
Viral vector-mediated 12/15-lipoxygenase overexpression in vascular smooth muscle cells enhances inflammatory gene expression and migration. J Vasc Res (2007) 0.85
RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles. Physiol Genomics (2013) 0.84
Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium. Am J Nephrol (2012) 0.83
Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. Diabetes Care (2004) 0.83
The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth. Arterioscler Thromb Vasc Biol (2005) 0.80
Epigenetics of diabetic complications. Expert Rev Endocrinol Metab (2010) 0.80
Role of epigenetic mechanisms in the vascular complications of diabetes. Subcell Biochem (2013) 0.79
Noncoding RNAs in vascular disease. Curr Opin Cardiol (2014) 0.79
12-Lipoxygenase metabolism in mouse distal convoluted tubule cells. Kidney Int (2005) 0.78
The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome. Prev Cardiol (2007) 0.78
Epigenetic mechanisms. Contrib Nephrol (2011) 0.78
Drugs targeting epigenetic histone acetylation in vascular smooth muscle cells for restenosis and atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 0.77
RLIP76 protein knockdown attenuates obesity due to a high-fat diet. J Biol Chem (2013) 0.77
Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species. Kidney Int (2011) 0.77
Forgetting to switch off SMAD2 in aneurysmal disease. Circ Res (2013) 0.75
Erratum: Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy. Sci Rep (2017) 0.75